TRIAL IN PROGRESS OF ENGOT-CX8/GOG-3024/INNOVATV 205: ADDITION OF A NEW COHORT USING FIRST-LINE TISOTUMAB VEDOTIN plus PEMBROLIZUMAB plus CARBOPLATIN +/- BEVACIZUMAB IN RECURRENT/METASTATIC CERVICAL CANCER
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要